Molecular Partners Says Phase 1/2A Study With Radio-Darpin Mp0712 Initiated

Reuters
2026.01.11 20:04

Molecular Partners AG :MOLECULAR PARTNERS AG - PHASE 1/2A STUDY WITH RADIO-DARPIN MP0712 INITIATEDMOLECULAR PARTNERS AG - PHASE 2 TRIAL OF MP0317 OPEN FOR CHOLANGIOCARCINOMAMOLECULAR PARTNERS AG - PHASE 1/2A TRIAL OF MP0533 ONGOING

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer